You are receiving this email because you signed up to receive our free e-letter Dividend Investor Hotline, or you purchased a product or service from its publisher, Eagle Financial Publications.
Med-X is preparing for a Nasdaq listing (MXRX)-but by the time the bell rings, it may be too late. Already generating $6.4M in revenue, its Nature-Cide line is sold e-commerce giants like Amazon, Walmart, and Kroger and is expanding into 41+ markets.
As regulators, consumers, and climate pressure push the $17B pest control industry natural, Med-X is positioned to lead. Right now, shares are just $4.00 through a limited Reg A+ offering.
From dwindling supplies caused by environmental mining restrictions and central bank hoarding… to global uncertainty regarding President Trump's policies… and stubborn inflation… Gold in the midst of a perfect storm. One that could easily send the pricing soaring to $6,000 an ounce, or possibly even higher. And my top investing expert, Jim Woods, wants to send you the details on two investments that could hand investors gains of up to 2,066%.
That's the window where real money is made in trading.
Not reacting to yesterday's news. Not hoping today's trend continues. But knowing what's setting up for the next 3 days before it shows up on anyone else's radar.
Right now, this A.I. is revealing setups that won't be obvious until it's too late for most traders.
The next 72 hours are already in motion. Are you positioned?
Eagle Financial Publications is located in Rosslyn, VA. – Blocks from the Capitol. Our products have been helping investors build their wealth for several decades. Whether you’re a long-term investor or short-term trader, you’ll find the right strategy for you, including how to earn more steady income to spend now, preserve and grow your capital to enjoy later, and whatever other investment goals you have.
To ensure future delivery of Eagle Financial Publication's emails please add the domain @info2.eaglefinancialpublications.com to your address book or contact list.
This email was sent to indra21poetra@gmail.com because you are subscribed to the Dividend Investor Hotline List. To unsubscribe please click here. To instantly stop receiving emails simply click here. View this email in your web browser.
Tidak ada komentar:
Posting Komentar